Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UMN-0501 H5N1 vaccine dose escalation
NCT00980447Phase 2Completed
- Sponsor
- UMN Pharma Inc.
- Start
- Oct 2009
- Primary completion
- Dec 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of UMN-0501, sponsored by UMN Pharma Inc.. Started Oct 2009; status: completed.
02
Drugs
UMN-0501
Beyond the preview
Go deeper on NCT00980447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00980447.